Medicine and Dentistry
Lung Cancer
100%
Sigma 2 Opiate Receptor
100%
Combination Therapy
100%
Erlotinib
69%
Plasma
30%
Neoplasm
30%
Epidermal Growth Factor Receptor
20%
In Vitro
20%
Lung Tumor
20%
Association
10%
Biological Marker
10%
Therapeutic Procedure
10%
Protein
10%
Motivation
10%
Chemotherapeutic Agent
10%
Receptor
10%
Patient
10%
Drug
10%
Inpatient
10%
Cancer
10%
Cancer Growth
10%
EGFR Inhibitors
10%
Metastatic Carcinoma
10%
Mortality Rate
10%
Progesterone Receptor
10%
Membrane Component
10%
Tumor Progression
10%
Diagnosis
10%
Chemotherapy
10%
Pharmacology, Toxicology and Pharmaceutical Science
Lung Cancer
100%
Sigma 2 Opiate Receptor
100%
Erlotinib
69%
Neoplasm
30%
Lung Tumor
20%
Cancer Growth
10%
Drug Binding Protein
10%
Cytochrome
10%
Protein
10%
Receptor
10%
Mortality Rate
10%
Biological Marker
10%
Tumor Growth
10%
Drug
10%
Metastasis
10%
Progesterone Receptor
10%